Navigation Links
Predicting The Risk Of A Heart Attack

A certain biomarker in the blood may predict the risk of heart attack or death for patients with coronary heart disease //, according to a new study.

Researchers conducted a study to determine whether blood levels of placental growth factor (PIGF) can predict risk for death or non-fatal heart attack in patients with acute chest pain. PIGF is a member of the vascular growth factor family and it acts as an instigator of hardening and narrowing of the arteries. Researchers took various measurements from 547 patients with acute coronary syndrome (ACS) and 626 patients who visited emergency rooms complaining of chest pain.

The researchers found that in patients with ACS, elevated PIGF levels indicated a higher rate of non-fatal heart attacks or death. It was seen that, patients with elevated levels were more than three-times more likely to experience these cardiac events than patients without elevated levels. In patients with acute chest pains, those with high PIGF levels were also at significantly increased risk compared with patients with low PIGF levels.

Researchers conclude that PIGF blood levels are valuable predictors of outcomes in patients with known or suspected ACS. They also say that, “PIGF plasma levels represent a potentially powerful clinical biomarker of vascular inflammation and adverse outcomes in patients with ACS.”

Thus Measuring PIGF levels may extend the predictive and prognostic information gained from traditional inflammatory markers.
'"/>




Page: 1

Related medicine news :

1. Predicting The Risk Of Preeclampsia During Pregnancy
2. Predicting Severity Of Appendicitis With Computed Tomography
3. Predicting The Risk Of Breast Cancer In The Future
4. Predicting The Risk Of Osteoarthritis
5. Predicting Breast Cancer Recurrence By Understanding Gene Signature
6. Researchers Find Mix of Biomarkers Predicting Mortality
7. Biomarkers Predicting Mortality Found Using Statistical Technique
8. HIV RNA Level Seen As Little Value In Predicting Treatment
9. Predicting the Dynamics of Clotting in Human Blood
10. Follicle Count Test as Good as Hormone Tests in Predicting Ovarian Response
11. One in Three Heart Attack Patients Have No Chest Pains
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
(Date:12/8/2016)... ... , ... STAT courier is pleased to announce that due to customer demand, ... expanding their presence in Dallas. One of the most exciting parts for STAT is ... the Dallas and Forth Worth market. STAT takes pride in treating their employees with ...
(Date:12/8/2016)... ... 08, 2016 , ... Vida Health, the digital health platform that ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor ... more consumers who are managing chronic conditions or simply want to improve ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
(Date:12/8/2016)... A Small Business Innovative Research (SBIR) grant ... (NIH) to Phoenix -based NeuroEM Therapeutics, ... grant will seek to determine an optimal set of ... waves to treat Alzheimer,s Disease. The grant will also ... treat other neurologic disorders such as Parkinson,s Disease and ...
(Date:12/8/2016)... New York , December 8, 2016 ... global Diabetes Injection Pens Market is expected to ... compared to US$4.9 bn in 2015. Between the forecast years ... rise at a CAGR of 7.9%. The leading players operating ... A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and ...
Breaking Medicine Technology: